TWiM explains how ticagrelor alters the membrane of S. aureus and enhances the activity of vancomycin and daptomycin without eliciting cross-resistance, and the development of a novel continuous disinfectant technology that decreases healthcare-associated infections in ICUs by 70%.
Hosts: Vincent Racaniello, Michael Schmidt, and Michele Swanson.
Become a patron of TWiM.
Links for this episodeSend your microbiology questions and comments (email or recorded audio) to [email protected]